We have updated the system! As some of you may be aware, one of the outcomes for Year 3 of the Community Pharmacy Contractual Framework is an expansion of the New Medicine Service (NMS).
To support our customers, RxWeb has been updated this week so that any newly prescribed medicines dispensed under one of the thirteen new categories and that are listed on the published NMS Drug Lists ( New Medicine Service (NMS) – Drug Lists | NHSBSA ), will be flagged to the user during the dispensing process, subject to you having NMS switched on in your system configuration.
NMS Expansion categories:
- Acute coronary syndrome (ACS);
- Atrial fibrillation (AF);
- Coronary heart disease;
- Epilepsy;
- Glaucoma;
- Gout;
- Heart failure;
- Hypercholesterolaemia ;
- Long term risks of venous thromboembolism/embolism;
- Osteoporosis;
- Parkinson’s Disease;
- Stroke / transient ischemic attack; and
- Urinary incontinence and retention.
Please note that the current NMS eligible conditions/medicines will also continue as before, but the antiplatelet/anticoagulant therapy group is now included in the above list by reference to the underlying condition/reason for prescribing.
Related news
Your RxWeb Q3 Release Is Here!
We’re excited to let you know that the RxWeb Q3 Release (R3 – October 2025) is here! This update introduces a wide range of new features and enhancements designed to make your daily workflows faster, smarter, and more efficient.
Pharmacy Profits Are Plummeting – Here’s How RxWeb Is Helping Pharmacies Fight Back
According to a new report from the Independent Pharmacies Association (IPA), community pharmacies across the UK are in financial free fall.
Fit for the Future: How RxWeb is Empowering UK Pharmacies & the NHS
On 3 July 2025, the UK government unveiled its landmark 10-year Health Plan for England, titled “Fit for the Future”. The plan lays out a bold roadmap to transform the NHS into a digitally advanced, community-first, and prevention-driven health service.